2025 ISPE Europe Annual Conference Debuts New Workshops and Announces Keynote Speakers

16 April, 2025

The 2025 ISPE Europe Annual Conference will take place 12 – 14 May in London, United Kingdom (UK) and virtually.

ISPE has announced its keynote speakers and plans to debut new workshops at the 2025 ISPE Europe Annual Conference, taking place Monday, 12 May, through Wednesday, 14 May, in London, UK and virtually.

The conference agenda is meticulously crafted to reflect current dynamics in the pharmaceutical landscape, with useful case studies around navigating regulatory expectations, implementing Pharma 4.0™, and exploring emerging technologies such as AI and machine learning, virtual and augmented reality, and smart manufacturing. Attendees will also learn about topics that are relevant to their day-to-day work, from assessing risks to designing test approaches and setting baseline metrics.

The 2025 ISPE Europe Annual Conference has a strong regulatory presence with European health authorities attending and presenting. "I look forward to participating in the 2025 ISPE Europe Annual Conference," said Evdokia Korakianiti, Head of Quality and Safety of Medicines, European Medicines Agency (EMA). "I plan to present on the role of regulators as enablers for innovation to facilitate the development of new therapies and enhance the supply of existing medicines to patients."

Confirmed featured speakers include:

Kevin Bailey
GMP Inspector
MHRA
Vanessa Bennett
Senior Medicines and Medical Device Shortage Specialist
European Medicines Agency
Brendan Cuddy
Lead Scientific Officer
EMA
Ian Jackson
Expert GMP Inspector
MHRA
Evdokia Korakianiti
Head of Quality and Safety of Medicines
EMA
Rasmus Pedersen
Associate Director, KojoX & Technology Development
FUJIFILM Diosynth Biotechnologies
James Pound
Deputy Director Standards and Compliance
MHRA
Ilaria Lo Presti
Senior Manager, PSC Global Engineering
GSK
Kirsty Reid
Director, Science Policy
EFPIA

Attendees will have the chance to hear from industry leaders and regulators who will share their perspectives on some of the most important topics the pharmaceutical industry is facing: sustainability and drug shortages, digital transformation, GAMP®, biotechnology in large molecules, cell and gene therapy, advanced therapeutical medicinal products (ATMPs), good engineering practice, and investment management. They can also participate in workshops, which are being included as part of the conference program for the first time this year.

Heather Watson 

The new workshops will cover the following topics:

  • “Drug Shortages”
  • “Digital Transformation and GAMP”
  • “Substances of Concern and Sustainability”
  • "Critical Success Factors for Digital Transformation Excellence"

Learn more and Register